{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:21:06Z","timestamp":1794244866014,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2025A1515012448; 2022A1515010033"],"award-info":[{"award-number":["2025A1515012448; 2022A1515010033"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanwei\u00a0Science\u00a0and\u00a0Technology\u00a0Plan\u00a0Project","award":["2023C007"],"award-info":[{"award-number":["2023C007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02908-x","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:35:07Z","timestamp":1777631707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection"],"prefix":"10.1186","volume":"24","author":[{"given":"Wanying","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunxian","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingrong","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"3","key":"2908_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2908_CR2","first-page":"561","volume":"91","author":"SM Penny","year":"2020","unstructured":"Penny SM. Ovarian cancer: an overview. Radiol Technol. 2020;91(6):561\u201375.","journal-title":"Radiol Technol"},{"issue":"4","key":"2908_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","volume":"29","author":"N Colombo","year":"2019","unstructured":"Colombo N, Sessa C, Bois AD, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer. 2019;29(4):728\u201360.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2908_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.23736\/S0026-4806.19.06086-5","volume":"110","author":"P Giampaolino","year":"2019","unstructured":"Giampaolino P, Della Corte L, Foreste V, et al. Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer. Minerva Med. 2019;110(4):279\u201391.","journal-title":"Minerva Med"},{"issue":"10290","key":"2908_CR5","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182\u201393.","journal-title":"Lancet"},{"issue":"13","key":"2908_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.21037\/atm.2017.05.13","volume":"5","author":"M Montagnana","year":"2017","unstructured":"Montagnana M, Benati M, Danese E. Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective. Ann Transl Med. 2017;5(13):276.","journal-title":"Ann Transl Med"},{"issue":"2","key":"2908_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hep.32308","volume":"76","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang Z, Tang W, et al. Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics. Hepatology. 2022;76(2):317\u201329.","journal-title":"Hepatology"},{"issue":"9","key":"2908_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1164\/rccm.202109-2019OC","volume":"207","author":"S Wang","year":"2023","unstructured":"Wang S, Meng F, Li M, et al. Multidimensional cell-free DNA fragmentomic assay for detection of early-stage lung cancer. Am J Respir Crit Care Med. 2023;207(9):1203\u201313.","journal-title":"Am J Respir Crit Care Med"},{"key":"2908_CR9","doi-asserted-by":"publisher","first-page":"104131","DOI":"10.1016\/j.ebiom.2022.104131","volume":"81","author":"W Guo","year":"2022","unstructured":"Guo W, Chen X, Liu R, et al. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling. EBioMedicine. 2022;81:104131.","journal-title":"EBioMedicine"},{"issue":"1","key":"2908_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-022-01594-w","volume":"21","author":"H Bao","year":"2022","unstructured":"Bao H, Wang Z, Ma X, et al. Letter to the editor: an ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection. Mol Cancer. 2022;21(1):129.","journal-title":"Mol Cancer"},{"issue":"7761","key":"2908_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","volume":"570","author":"S Cristiano","year":"2019","unstructured":"Cristiano S, Leal A, Phallen J, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019;570(7761):385\u20139.","journal-title":"Nature"},{"issue":"1","key":"2908_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-021-01189-w","volume":"14","author":"X Ma","year":"2021","unstructured":"Ma X, Chen Y, Tang W, et al. Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma. J Hematol Oncol. 2021;14(1):175.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2908_CR13","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1038\/s41467-021-24994-w","volume":"12","author":"D Mathios","year":"2021","unstructured":"Mathios D, Johansen JS, Cristiano S, et al. Detection and characterization of lung cancer using cell-free DNA fragmentomes. Nat Commun. 2021;12(1):5060.","journal-title":"Nat Commun"},{"issue":"22","key":"2908_CR14","doi-asserted-by":"publisher","first-page":"14197","DOI":"10.3390\/ijms232214197","volume":"23","author":"C Gianni","year":"2022","unstructured":"Gianni C, Palleschi M, Merloni F, et al. Cell-free DNA fragmentomics: a promising biomarker for diagnosis, prognosis and prediction of response in breast cancer. Int J Mol Sci. 2022;23(22):14197.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2908_CR15","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.xcrm.2023.101198","volume":"4","author":"SM Batool","year":"2023","unstructured":"Batool SM, Yekula A, Khanna P, et al. The liquid biopsy consortium: challenges and opportunities for early cancer detection and monitoring. Cell Rep Med. 2023;4(10):101198.","journal-title":"Cell Rep Med"},{"issue":"13 Suppl","key":"2908_CR16","doi-asserted-by":"publisher","first-page":"A035","DOI":"10.1158\/1557-3265.AIMACHINE-A035","volume":"31","author":"S Farashahi","year":"2025","unstructured":"Farashahi S, et al. Abstract A035: denoising models enhance detection of tumor-derived cfDNA fragments and cancer tissue signal in liquid biopsy. Clin Cancer Res. 2025;31(13 Suppl):A035.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2908_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13073-021-00952-5","volume":"13","author":"BM Barnes","year":"2021","unstructured":"Barnes BM, Nelson L, Tighe A, et al. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes. Genome Med. 2021;13(1):140.","journal-title":"Genome Med"},{"issue":"1","key":"2908_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/JS9.0000000000001875","volume":"111","author":"Y Yu","year":"2025","unstructured":"Yu Y, Ouyang W, Huang Y, et al. Artificial intelligence-based multi-modal multi-tasks analysis reveals tumor molecular heterogeneity, predicts preoperative lymph node metastasis and prognosis in papillary thyroid carcinoma: a retrospective study. Int J Surg. 2025;111(1):839\u201356.","journal-title":"Int J Surg"},{"key":"2908_CR19","doi-asserted-by":"publisher","first-page":"118225","DOI":"10.1016\/j.ecoenv.2025.118225","volume":"297","author":"W Ouyang","year":"2025","unstructured":"Ouyang W, Zhu C, Li Y, Huang H, Li F, Ling L. Assessing the neurotoxic risks of triethyl citrate in daily environmental exposure using network toxicology and molecular docking. Ecotoxicol Environ Saf. 2025;297:118225.","journal-title":"Ecotoxicol Environ Saf"},{"key":"2908_CR20","doi-asserted-by":"publisher","first-page":"217159","DOI":"10.1016\/j.canlet.2024.217159","volume":"601","author":"W Ouyang","year":"2024","unstructured":"Ouyang W, Huang Z, Wan K, Nie T, Chen H, Yao H. RNA ac(4)C modification in cancer: unraveling multifaceted roles and promising therapeutic horizons. Cancer Lett. 2024;601:217159.","journal-title":"Cancer Lett"},{"issue":"15","key":"2908_CR21","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"14","key":"2908_CR22","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"key":"2908_CR23","doi-asserted-by":"publisher","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv:1303.3997. 2013. https:\/\/doi.org\/10.48550\/arXiv.1303.3997.","DOI":"10.48550\/arXiv.1303.3997"},{"issue":"1","key":"2908_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12885-019-6003-8","volume":"19","author":"N Wan","year":"2019","unstructured":"Wan N, Weinberg D, Liu TY, et al. Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA. BMC Cancer. 2019;19(1):832.","journal-title":"BMC Cancer"},{"issue":"1","key":"2908_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","volume":"8","author":"VA Adalsteinsson","year":"2017","unstructured":"Adalsteinsson VA, Ha G, Freeman SS, et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun. 2017;8(1):1324.","journal-title":"Nat Commun"},{"issue":"466","key":"2908_CR26","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1126\/scitranslmed.aat4921","volume":"10","author":"F Mouliere","year":"2018","unstructured":"Mouliere F, Chandrananda D, Piskorz AM, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018;10(466):4921.","journal-title":"Sci Transl Med"},{"issue":"11","key":"2908_CR27","doi-asserted-by":"publisher","first-page":"E1317","DOI":"10.1073\/pnas.1500076112","volume":"112","author":"P Jiang","year":"2015","unstructured":"Jiang P, Chan CW, Chan KC, et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A. 2015;112(11):E1317\u201325.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2908_CR28","doi-asserted-by":"publisher","unstructured":"Ding SC, Lo YMD. Cell-free DNA fragmentomics in liquid biopsy. Diagnostics (Basel). 2022;12(4):978. https:\/\/doi.org\/10.3390\/diagnostics12040978.","DOI":"10.3390\/diagnostics12040978"},{"issue":"1","key":"2908_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13059-021-02459-z","volume":"22","author":"I Georgakopoulos-Soares","year":"2021","unstructured":"Georgakopoulos-Soares I, Yizhar-Barnea O, Mouratidis I, Hemberg M, Ahituv N. Absent from DNA and protein: genomic characterization of nullomers and nullpeptides across functional categories and evolution. Genome Biol. 2021;22(1):245.","journal-title":"Genome Biol"},{"issue":"20","key":"2908_CR30","doi-asserted-by":"publisher","first-page":"e70316","DOI":"10.1002\/cam4.70316","volume":"13","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li C, Yang Y, et al. Predicting disease progression in inoperable localized NSCLC patients using ctDNA machine learning model. Cancer Med. 2024;13(20):e70316.","journal-title":"Cancer Med"},{"issue":"8","key":"2908_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, et al. Variant interpretation using population databases: lessons from gnomAD. Hum Mutat. 2022;43(8):1012\u201330.","journal-title":"Hum Mutat"},{"issue":"12","key":"2908_CR32","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2908_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1\u20135.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"2908_CR34","doi-asserted-by":"publisher","first-page":"e12890","DOI":"10.1111\/acel.12890","volume":"18","author":"YV Teo","year":"2019","unstructured":"Teo YV, Capri M, Morsiani C, et al. Cell-free DNA as a biomarker of aging. Aging Cell. 2019;18(1):e12890.","journal-title":"Aging Cell"},{"issue":"10226","key":"2908_CR35","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","volume":"395","author":"GR Dagenais","year":"2020","unstructured":"Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2020;395(10226):785\u201394.","journal-title":"Lancet"},{"issue":"8","key":"2908_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10462-024-10872-6","volume":"57","author":"S Gandotra","year":"2024","unstructured":"Gandotra S, Kumar Y, Modi N, Choi J, Shafi J, Ijaz MF. Comprehensive analysis of artificial intelligence techniques for gynaecological cancer: symptoms identification, prognosis and prediction. Artif Intell Rev. 2024;57(8):220.","journal-title":"Artif Intell Rev"},{"issue":"2","key":"2908_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ygyno.2012.11.022","volume":"128","author":"RE Bristow","year":"2013","unstructured":"Bristow RE, Smith A, Zhang Z, et al. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay. Gynecol Oncol. 2013;128(2):252\u20139.","journal-title":"Gynecol Oncol"},{"issue":"19","key":"2908_CR38","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.3390\/ijms231912041","volume":"23","author":"R Zhang","year":"2022","unstructured":"Zhang R, Siu MKY, Ngan HYS, et al. Molecular biomarkers for the early detection of ovarian cancer. Int J Mol Sci. 2022;23(19):12041.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2908_CR39","doi-asserted-by":"publisher","first-page":"228.e1","DOI":"10.1016\/j.ajog.2010.03.043","volume":"203","author":"RG Moore","year":"2010","unstructured":"Moore RG, Jabre-Raughley M, Brown AK, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol. 2010;203(3):228.e1-228.e66.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2908_CR40","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/cancers13040838","volume":"13","author":"XM Guo","year":"2021","unstructured":"Guo XM, Miller H, Matsuo K, et al. Circulating cell-free DNA methylation profiles in the early detection of ovarian cancer: a scoping review of the literature. Cancers Basel. 2021;13(4):838.","journal-title":"Cancers Basel"},{"issue":"6","key":"2908_CR41","doi-asserted-by":"publisher","first-page":"e0155495","DOI":"10.1371\/journal.pone.0155495","volume":"11","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Li W, Leng B, et al. Circulating Cell Free DNA as the diagnostic marker for ovarian cancer: a systematic review and meta-analysis. PLoS ONE. 2016;11(6):e0155495.","journal-title":"PLoS ONE"},{"key":"2908_CR42","doi-asserted-by":"publisher","first-page":"143993","DOI":"10.1016\/j.gene.2019.143993","volume":"714","author":"B Li","year":"2019","unstructured":"Li B, Pu K, Ge L, Wu X. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis. Gene. 2019;714:143993.","journal-title":"Gene"},{"key":"2908_CR43","first-page":"1","volume":"50","author":"K Sandrasegaran","year":"2025","unstructured":"Sandrasegaran K, Das A, Shah A, et al. Serous borderline ovarian tumor and low-grade serous ovarian cancer. Abdom Radiol (NY). 2025;50:1\u201313.","journal-title":"Abdom Radiol (NY)"},{"key":"2908_CR44","unstructured":"National Cancer Institute. SEER Cancer Stat Facts: Ovarian Cancer. Reviewed. 2024. https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html. Accessed 5 Sept 2025."},{"issue":"1","key":"2908_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","volume":"21","author":"S Connal","year":"2023","unstructured":"Connal S, Cameron JM, Sala A, et al. Liquid biopsies: the future of cancer early detection. J Transl Med. 2023;21(1):118.","journal-title":"J Transl Med"},{"issue":"9","key":"2908_CR46","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S1470-2045(23)00335-2","volume":"24","author":"U Menon","year":"2023","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, et al. Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial. Lancet Oncol. 2023;24(9):1018\u201328.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2908_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/1055-9965.EPI-20-1134","volume":"30","author":"E Hubbell","year":"2021","unstructured":"Hubbell E, Clarke CA, Aravanis AM, et al. Modeled reductions in late-stage cancer with a multi-cancer early detection test. Cancer Epidemiol Biomarkers Prev. 2021;30(3):460\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02908-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02908-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02908-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:03:30Z","timestamp":1781831010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02908-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2908"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02908-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committees of Sun Yat-sen Memorial Hospital (approval No. SYSKY-2022\u2013485-02) and Jiangmen Central Hospital (approval No. [2022]53). Written informed consent was obtained from all participants before sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.W., D.Z., and H.B. are employees of Nanjing Geneseeq Technology Inc. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}